Osamu Ishikawa 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（20 件）

• [2024] Effectiveness and safety of low-energy shock wave therapy for digital ulcers associated with systemic sclerosis: A Phase 3 pivotal clinical trial
  DOI: https://doi.org/10.1093/mr/roae104
• [2024] A case of dominant dystrophic epidermolysis bullosa pruriginosa with a novel mutation in the hinge region of COL7A1
  DOI: https://doi.org/10.3389/jcia.2024.12844
• [2024] Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
  DOI: https://doi.org/10.1093/rheumatology/keae150
• [2023] Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
  DOI: https://doi.org/10.1016/s2665-9913(23)00238-2
• [2023] Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer
  DOI: https://doi.org/10.1097/sla.0000000000005879
• [2023] DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
  DOI: https://doi.org/10.1186/s12885-023-10512-2
• [2022] Complete Recanalization in Mechanical Thrombectomy Is Associated with Favorable Functional Outcome for M2 Occlusions
  DOI: https://doi.org/10.5797/jnet.oa.2022-0057
• [2022] Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature
  DOI: https://doi.org/10.1186/s40792-022-01529-z
• [2022] Malignant melanoma of inner canthus with long‐term survival after resection of brain metastasis and treatment with ipilimumab
  DOI: https://doi.org/10.1002/cia2.12268
• [2022] DECREASED EXPRESSION OF BOTH A AND B BLOOD ANTIGENS IN A PATIENT WITH MYELODYSPLASTIC SYNDROME
  DOI: https://doi.org/10.3925/jjtc.68.428

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。